Immune response to vaccination with DNA-hsp65 in a phase I clinical trial with head and neck cancer patients

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Gene Therapy

• Publication date

  2009-02-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/cgt.2009.9PMID 19197326
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans

  2008cited by this paper
• The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

  2008cited by this paper
• Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck

  2008cited by this paper
• Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation

  2008cited by this paper
• Immune modulation induced by tuberculosis DNA vaccine protects non‐obese diabetic mice from diabetes progression

  2007cited by this paper
• Cellular autoreactivity against heat shock protein 60 in renal transplant patients: peripheral and graft‐infiltrating responses

  2006cited by this paper
• Gene-based vaccines: recent technical and clinical advances.

  2006cited by this paper
• Suppression of Antitumor Immunity by IL-10 and TGF-β-Producing T Cells Infiltrating the Growing Tumor: Influence of Tumor Environment on the Induction of CD4+ and CD8+ Regulatory T Cells1

  2006cited by this paper
• Preclinical and Clinical Safety Studies on DNA Vaccines

  2006cited by this paper
• DNA Vaccines: Recent Developments and Future Possibilities

  2006cited by this paper
• Immunobiology of head and neck cancer

  2005cited by this paper
• Immunomodulation and Protection Induced by DNA-hsp65 Vaccination in an Animal Model of Arthritis

  2005cited by this paper
• Heat-shock proteins induce T-cell regulation of chronic inflammation

  2005cited by this paper
• T-cell autoreactivity to Hsp in human transplantation may involve both proinflammatory and regulatory functions.

  2004cited by this paper
• Immune regulatory effect of pHSP65 DNA therapy in pulmonary tuberculosis: activation of CD8+ cells, interferon‐γ recovery and reduction of lung injury

  2004cited by this paper
• Molecular Chaperones in the Cytosol: from Nascent Chain to Folded Protein

  2002cited by this paper
• Mycobacterium tuberculosisChaperonin 60.1 Is a More Potent Cytokine Stimulator than Chaperonin 60.2 (Hsp 65) and Contains a CD14-Binding Domain

  2001cited by this paper
• Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells.

  2001cited by this paper
• Correlates of protective immunity to Mycobacterium tuberculosis in humans.

  2000cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

  2000cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors

  2000cited by this paper
• T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides.

  1999cited by this paper
• Therapy of tuberculosis in mice by DNA vaccination

  1999cited by this paper
• Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis.

  1999cited by this paper
• Human 60-kDa heat-shock protein: a danger signal to the innate immune system.

  1999cited by this paper
• Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world.

  1998cited by this paper
• Identification and Characterization of Protective T Cells in hsp65 DNA-Vaccinated and Mycobacterium tuberculosis-Infected Mice

  1998cited by this paper
• In vivo gene therapy of malignant tumours with heat shock protein-65 gene

  1997cited by this paper
• Vaccination against tuberculosis by DNA injection

  1996cited by this paper
• Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions.

  1993cited by this paper
• Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65.

  1992cited by this paper
• Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis.

  1991cited by this paper
• Heat shock, stress proteins, chaperones, and proteotoxicity.

  1991cited by this paper
• Removal of endotoxin from protein solutions by phase separation using Triton X-114.

  1990cited by this paper
• Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein.

  1990cited by this paper
• Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis

  1988cited by this paper
• Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans.

  1985cited by this paper

• Immunotherapy for Cancer: Strategies of Immunomodulation Therapy in Combination with Conventional Approaches

  2022cites this paper
• Immunopathology as a Basis for Immunotherapy of Head and Neck Squamous Cell Carcinoma

  2020cites this paper
• Identification of antigens presented by MHC for vaccines against tuberculosis

  2020influential citation
• Immunotherapeutic Activities of a DNA Plasmid Carrying the Mycobacterial hsp65 Gene (DNAhsp65)

  2020cites this paper
• Mycobacterial Hsp65 antigen upregulates the cellular immune response of healthy individuals compared with tuberculosis patients

  2017cites this paper
• HSP60 is a Ubiquitous Player in the Physiological and Pathogenic Interactions between the Chaperoning and the Immune Systems

  2017cites this paper
• A DNA Vaccine Formulated with Chemical Adjuvant Provides Partial Protection against Bovine Herpes Virus Infection in Cattle

  2017cites this paper
• Preclinical and clinical development of DNA vaccines for prostate cancer.

  2016cites this paper
• Surgical immune interventions for solid malignancies.

  2016cites this paper
• Endoplasmic Reticulum Chaperones and Their Roles in the Immunogenicity of Cancer Vaccines

  2015cites this paper
• Immunopathology of Head and Neck Tumors and Immunotherapy of Squamous Cell Carcinoma

  2015cites this paper
• Combined immunization using DNA-Sm14 and DNA-Hsp65 increases CD8+ memory T cells, reduces chronic pathology and decreases egg viability during Schistosoma mansoni infection

  2014cites this paper
• Heat-Shock Protein-Based Cancer Immunotherapy

  2014cites this paper
• A snapshot of gene therapy in Latin America

  2013cites this paper
• Trial watch

  2013cites this paper
• Trial Watch

  2013cites this paper
• Antigen-specific immunotherapy in head and neck cancer

  2013cites this paper
• TB Vaccines: State of the Art and Progresses

  2013cites this paper
• Immuntherapie von Kopf-Hals-Karzinomen

  2013cites this paper
• HSP60: Issues and Insights on Its Therapeutic Use as an Immunoregulatory Agent

  2012cites this paper
• Allergen‐free immunotherapy using DNA vaccines in treatment of established allergic disease

  2012cites this paper
• Heat shock proteins (HSPs) based anti-cancer vaccines.

  2012cites this paper
• Chaperonopathies and chaperonotherapy. Hsp60 as therapeutic target in cancer: potential benefits and risks.

  2012cites this paper
• Systemische Therapiestrategien bei Kopf-Hals-Karzinomen

  2012cites this paper
• Radiation-induced stress proteins - the role of heat shock proteins (HSP) in anti- tumor responses.

  2012cites this paper
• Cytoplasmic and extracellular expression of pharmaceutical-grade mycobacterial 65-kDa heat shock protein in Lactococcus lactis.

  2012cites this paper
• Novel targeted therapies in head and neck cancer

  2012cites this paper
• Recombinant DNA immunotherapy ameliorate established airway allergy in a IL‐10 dependent pathway

  2012cites this paper
• Systemic therapy strategies for head-neck carcinomas: Current status

  2012cites this paper
• Heat Shock Proteins in the Cancer Immunity: Comprehensive Review on Potential Chemotherapeutic Interventions

  2012cites this paper
• Emerging therapies in the treatment of locally advanced squamous cell cancers of head and neck.

  2011cites this paper
• Therapeutic cancer vaccines: are we there yet?

  2011cites this paper
• Avaliação de estratégias de vacinação "prime- boost" na infecção experimental por Schistosoma mansoni empregando vacinas de DNA

  2011cites this paper
• Immunology of Head and Neck Cancer

  2011cites this paper
• Immunotherapy for head and neck cancer: advances and deficiencies

  2011cites this paper
• Helminth Coinfection Does Not Affect Therapeutic Effect of a DNA Vaccine in Mice Harboring Tuberculosis

  2010cites this paper
• Tumor immunogenicity and responsiveness to cancer vaccine therapy: the state of the art.

  2010cites this paper
• umor immunogenicity and responsiveness to cancer vaccine therapy : The state f the art

  2010cites this paper
• The Impact of Transcriptomics on the Fight against Tuberculosis: Focus on Biomarkers, BCG Vaccination, and Immunotherapy

  2010cites this paper
• Balancing Effector and Regulatory T Cell Responses in Cancer and Autoimmunity

  2010cites this paper
• Advances in immunotherapy for tuberculosis treatment.

  2009cites this paper
• No Evidence of Pathological Autoimmunity following Mycobacterium Leprae Heat-Shock Protein 65-Dna Vaccination in Mice

  2009cites this paper
• Recent advances in DNA vaccines for autoimmune diseases

  2009cites this paper
• Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck

  2008cites this paper